Edition:
India

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

581.30INR
18 Jun 2018
Change (% chg)

-- (--)
Prev Close
Rs581.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
982,558
52-wk High
Rs746.00
52-wk Low
Rs493.50

Select another date:

Wed, May 30 2018

BUZZ-India's Glenmark Pharmaceuticals drops most in over 3 months

** Shares of Glenmark Pharmaceuticals Ltd fall nearly 5 pct to 505.5 rupees, their lowest since May 22

BRIEF-Glenmark Pharma Says Co Suspended Trial Conducted at Malpani Hospital After Alleged Irregularities

* CLARIFIES ON NEWS ITEM ABOUT CO GETTING NOTICE OVER MISCONDUCT IN CLINICAL TRIALS

MEDIA-India's Glenmark Pharma gets notice over misconduct in clinical trials - Mint

- Note: Reuters has not verified this story and does not vouch for its accuracy

BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Clobetasol Propionate Topical Solution USP

* GETS ANDA APPROVAL FOR CLOBETASOL PROPIONATE TOPICAL SOLUTION USP

BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Tacrolimus Ointment, 0.1 Pct

* SAYS CO GETS ANDA APPROVAL FOR TACROLIMUS OINTMENT, 0.1 PERCENT Source text - http://bit.ly/2HKxf5K Further company coverage:

BRIEF-Glenmark Pharmaceuticals, Helsinn Group Enter Into Agreement For Launch Of Akynzeo In India And Nepal

* SAYS CO, HELSINN GROUP ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR LAUNCH OF AKYNZEO IN INDIA AND NEPAL

BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval From U.S. FDA For Clobetasol Propionate Spray, 0.05 Pct

* SAYS ‍CO GETS ANDA APPROVAL FROM U.S. FDA FOR CLOBETASOL PROPIONATE SPRAY, 0.05 PERCENT

BRIEF-Glenmark Pharma Enters Exclusive Collaboration Agreement with SCD Pharmaceuticals

* GLENMARK PHARMACEUTICALS - ‍ENTERED INTO EXCLUSIVE DEAL WITH SAM CHUN DANG PHARM

BUZZ-India's Glenmark Pharmaceuticals hits 44-mth low on disappointing Q3 results

** Shares of Glenmark Pharmaceuticals Ltd drop as much as 9.6 pct to 524 rupees, lowest since May 28, 2014

BRIEF-India's Glenmark Pharmaceuticals Dec-Qtr Consol Profit Falls 78 Pct

* DEC QUARTER CONSOL PROFIT 1.05 BILLION RUPEES VERSUS PROFIT OF 4.77 BILLION RUPEES LAST YEAR

Select another date: